Cyclerion Therapeutics (NASDAQ:CYCN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cyclerion Therapeutics Stock (NASDAQ: CYCN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 211.04K
Day Range	- - -
52 Wk Range	1.71 - 5.25
Market Cap	$5.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.78%
Days to Cover	1

Recent News

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 211.04K
Day Range	- - -
52 Wk Range	1.71 - 5.25
Market Cap	$5.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.78%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cyclerion Therapeutics (CYCN) stock?

You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.

View our list of the best stock brokerages

Who are Cyclerion Therapeutics (CYCN) competitors?

Other companies in Cyclerion Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), ABVC BioPharma (NASDAQ:ABVC), Portage Biotech (NASDAQ:PRTG), Viracta Therapeutics (NASDAQ:VIRX) and TransCode Therapeutics (NASDAQ:RNAZ).

What is the forecast, or price target, for Cyclerion Therapeutics (CYCN) stock?

There is no analysis for Cyclerion Therapeutics to provide a consensus price target.

What is the current price for Cyclerion Therapeutics (CYCN)?

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $2.02 last updated November 20, 2024 at 6:44 PM EST.

Does Cyclerion Therapeutics (CYCN) pay a dividend?

There are no upcoming dividends for Cyclerion Therapeutics.

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

Cyclerion Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is Cyclerion Therapeutics (CYCN) going to split?

There is no upcoming split for Cyclerion Therapeutics.

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Cyclerion Therapeutics

Cyclerion Therapeutics (CYCN) Forecast